Related Experiment Video
Updated: Aug 20, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Site-specific cholesterol depletion therapy for gastric cancer
Simona Kavrakova1, Ashutosh Sharma1, Elena Ristevska1
1Department of Chemistry, University of Illinois Chicago, Chicago, IL 60607, U.S.A.
Abstract:
Altered cholesterol metabolism is a recognized hallmark of cancer, but systemic modulation has not yet delivered significant clinical results. Accumulating evidence shows that cholesterol plays distinct roles across diverse cellular membranes, suggesting that site-specific modulation may produce superior therapeutic outcomes. Cholesterol is associated with gastric cancer (GC), but the mechanistic link is complex and no effective cholesterol-targeted therapy has been developed. Here, we report that cholesterol levels in GC cells are site-specifically elevated in the inner leaflet of the plasma membrane (IPM). This elevated IPM cholesterol constitutively activates Wnt-β-catenin signaling to drive cell survival and proliferation. Mechanistically, Niemann-Pick C1-like 1 (NPC1L1), which is highly expressed in GC patient tissues and cell lines, acts as a cholesterol flippase to raise IPM cholesterol levels, facilitating ligand-independent β-catenin signalosome formation. Ezetimibe, a clinically approved NPC1L1 inhibitor, blocks this flippase activity, lowers IPM cholesterol levels, and suppresses β-catenin signaling. Ezetimibe treatment induces apoptosis in GC cells while sparing normal primary gastric epithelial cells, which exhibit low levels of NPC1L1 and IPM cholesterol. Collectively, these results suggest that site-specific modulation of cellular cholesterol is a viable approach to developing safe and effective therapies for cancers linked to local cholesterol elevation.
Insights
Gastric cancer cells show elevated cholesterol in the inner plasma membrane, activating survival pathways. Inhibiting cholesterol transport with ezetimibe selectively kills cancer cells, offering a targeted therapy approach.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Altered cholesterol metabolism is a hallmark of cancer, yet systemic therapies lack efficacy.
- Cholesterol's role varies across cellular membranes, suggesting site-specific targeting is key.
- The link between cholesterol and gastric cancer (GC) is complex, with no targeted therapies available.
Purpose of the Study:
- To investigate the site-specific role of cholesterol in gastric cancer.
- To identify mechanisms driving GC cell survival related to cholesterol.
- To evaluate the therapeutic potential of targeting cholesterol metabolism in GC.
Main Methods:
- Analysis of cholesterol distribution in GC cells.
- Investigating the role of Niemann-Pick C1-like 1 (NPC1L1) in cholesterol transport.
- Treatment of GC cells and patient tissues with ezetimibe, an NPC1L1 inhibitor.
- Assessment of Wnt-β-catenin signaling activation and apoptosis induction.
Main Results:
- Cholesterol levels are specifically elevated in the inner plasma membrane (IPM) of GC cells.
- Elevated IPM cholesterol activates Wnt-β-catenin signaling, promoting GC cell survival and proliferation.
- NPC1L1, highly expressed in GC, acts as a cholesterol flippase, increasing IPM cholesterol.
- Ezetimibe inhibits NPC1L1, reduces IPM cholesterol, suppresses Wnt-β-catenin signaling, and induces apoptosis in GC cells while sparing normal cells.
Conclusions:
- Site-specific elevation of IPM cholesterol drives gastric cancer progression.
- NPC1L1-mediated cholesterol transport is a critical mechanism in GC.
- Ezetimibe demonstrates therapeutic potential by selectively targeting cholesterol-dependent GC cell survival.
- Targeting localized cholesterol metabolism offers a promising strategy for gastric cancer therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...